Beta-carboline derivatives and its pharmaceutical use aginst depression and anxiety
申请人:——
公开号:US20040132735A1
公开(公告)日:2004-07-08
The invention provides compounds of formula (I) wherein R1 to R5 are as defined in the description, and their preparation. The compounds of formula (I) are useful as pharmaceuticals.
1
BETA-CARBOLINE DERIVATIVES AND ITS PHARMACEUTICAL USE AGAINST DEPRESSION AND ANXIETY
申请人:Novartis AG
公开号:EP1377578A1
公开(公告)日:2004-01-07
Diagnosis and treatment of type 2 diabetes and other disorders
申请人:Zhou Yun-Ping
公开号:US20090131451A1
公开(公告)日:2009-05-21
The present application features the use of the somatostatin subtype 3 receptor (SST3) as a target for affecting insulin secretion and for diagnosing diabetes related disorders. Glucose stimulated insulin secretion was found to be stimulated by knocking down expression of SST3 and through the use of a SST3 selective antagonist.